The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer
Open accessAbstract
Bevacizumab plays an important role in the first and second line treatment for metastatic colorectal cancer (CRC). And induction of hypoxia and the tumors response to it plays an important role in determining the efficacy of antiangiogenic therapy while the connection between them remains unclear. Here, we found that lactate accumulated in the tumor environment of CRC and acted as substrates for histone lactylation, and this process was further induced by cellular enhanced glycolysis in hypoxia. We determined that CRC patients resistant to bevacizumab treatment presented with elevated levels of histone lactylation and inhibition of histone lactylation efficiently suppressed CRC tumorigenesis, progression and survival in hypoxia. Histone lactylation promoted the transcription of RUBCNL/Pacer, facilitating autophagosome maturation through interacting with BECN1 (beclin 1) and mediating the recruitment and function of the class III phosphatidylinositol 3-kinase complex, which had a crucial role in hypoxic cancer cells proliferation and survival. Moreover, combining inhibition of histone lactylation and macroautophagy/autophagy with bevacizumab treatment demonstrated remarkable treatment efficacy in bevacizumab-resistance patients-derived pre-clinical models. These findings delivered a new exploration and important supplement of metabolic reprogramming-epigenetic regulation, and provided a new strategy for improving clinical efficacy of bevacizumab in CRC by inhibition of histone lactylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Colorectal cancer statistics, 2020
Siegel, R. L., Miller, K. D., Goding Sauer, A., Fedewa, S. A., Butterly, L. F., Anderson, J. C., Cercek, A., Smith, R. A., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21601 · Cited by 4,880
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Metabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421 · cited 1×
“Recurrence and distant metastasis are still the leading causes of treatment failure and death among CRC patients [2,3].”
BackgroundExploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Autophagosome formation: core machinery and adaptations
Xie, Z., & Klionsky, D. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1007-1102 · Cited by 2,164
Autophagy: from phenomenology to molecular understanding in less than a decade
Klionsky, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2245 · Cited by 1,934
Van Cutsem, E., Köhne, C.-H., Láng, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5091 · Cited by 1,882
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Arain, M. A., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Farkas, L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0012 · Cited by 1,696
Garcia, J., Hurwitz, H. I., Sandler, A. B., Miles, D., Coleman, R. L., Deurloo, R., & Chinot, O. L. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102017 · Cited by 1,159 · cited 1×
“Despite the improvement in clinical outcomes for metastatic CRC as a result of antiangiogenic therapy, the majority of patients manifest intrinsic or acquired resistance to treatment and the overall benefit is limited eventually [16,17].”
BackgroundCovalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers
Chi, P., Allis, C. D., & Wang, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2876 · Cited by 1,099
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Maughan, T. S., Adams, R. A., Smith, C. G., Meade, A. M., Seymour, M. T., Wilson, R. H., Idziaszczyk, S., Harris, R., Fisher, D., Kenny, S. L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60613-2 · Cited by 960
Yu, J., Chai, P., Xie, M., Ge, S., Ruan, J., Fan, X., & Jia, R. (2021) · Genome Biology · doi:10.1186/s13059-021-02308-z · Cited by 940
Venook, A. P., Niedzwiecki, D., Lenz, H.-J., Innocenti, F., Fruth, B., Meyerhardt, J. A., Schrag, D., Greene, C., O'Neil, B. H., Atkins, J. N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7105 · Cited by 898
Xiong, J., He, J., Zhu, J., Pan, J., Liao, W., Ye, H., Wang, H., Song, Y., Du, Y., Cui, B., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.033 · Cited by 804
Self-citationCummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602235103 · Cited by 788
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
Vasudev, N. S., & Reynolds, A. R. (2014) · Angiogenesis · doi:10.1007/s10456-014-9420-y · Cited by 738
Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy
Feng, Y., Xiong, Y., Qiao, T., Li, X., Jia, L., & Han, Y. (2018) · Cancer Medicine · doi:10.1002/cam4.1820 · Cited by 705
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Keunen, O., Johansson, M., Oudin, A., Sanzey, M., Rahim, S. A. A., Fack, F., Thorsen, F., Taxt, T., Bartos, M., Jirik, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014480108 · Cited by 606
Yang, Z., Yan, C., Ma, J., Peng, P., Ren, X., Cai, S., Shen, X., Wu, Y., Zhang, S., Wang, X., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-022-00710-w · Cited by 589
Hu, Y.-L., DeLay, M., Jahangiri, A., Molinaro, A. M., Rose, S. D., Carbonell, W. S., & Aghi, M. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3831 · Cited by 483
Shi, Y.-H., Ding, Z.-B., Zhou, J., Hui, B., Shi, G.-M., Ke, A.-W., Wang, X.-Y., Dai, Z., Peng, Y.-F., Gu, C.-Y., et al. (2011) · Autophagy · doi:10.4161/auto.7.10.16818 · Cited by 344
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
Méndez-Blanco, C., Fondevila, F., García-Palomo, A., González-Gallego, J., & Mauriz, J. L. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0159-1 · Cited by 339
Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
Chen, A.-N., Luo, Y., Yang, Y.-H., Fu, J.-T., Geng, X.-M., Shi, J.-P., & Yang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688910 · Cited by 324
Sorensen, A. G., Emblem, K. E., Polaskova, P., Jennings, D., Kim, H., Ancukiewicz, M., Wang, M., Wen, P. Y., Ivy, P., Batchelor, T. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2464 · Cited by 295
Cao, D., Hou, M., Guan, Y.-S., Jiang, M., Yang, Y., & Gou, H.-F. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-432 · Cited by 244
Yang, J., Luo, L., Zhao, C., Li, X., Wang, Z., Zeng, Z., Yang, X., Zheng, X., Jie, H., Kang, L., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73398 · Cited by 240
Self-citationAutophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy
Selvakumaran, M., Amaravadi, R. K., Vasilevskaya, I. A., & O'Dwyer, P. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1542 · Cited by 221
Tomasello, G., Petrelli, F., Ghidini, M., Russo, A., Passalacqua, R., & Barni, S. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0278 · Cited by 204
Inflammatory signaling cascades and autophagy in cancer
Monkkonen, T., & Debnath, J. (2018) · Autophagy · doi:10.1080/15548627.2017.1345412 · Cited by 186
Hurwitz, H. (2004) · Clinical Colorectal Cancer · doi:10.3816/ccc.2004.s.010 · Cited by 165
Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice
Milkiewicz, M., Pugh, C. W., & Egginton, S. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.069757 · Cited by 165
Wu, H., Yang, S., Weng, H., Chen, Q., Zhao, X., Fu, W., Niu, Q., Ping, Y., Wang, J., Zhang, X., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1336277 · Cited by 148
Botrel, T. E. A., Clark, L. G. D. O., Paladini, L. M., & Clark, O. A. C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2734-y · Cited by 130
Targeting Hypoxia-Inducible Factors for Antiangiogenic Cancer Therapy
Rey, S., Schito, L., Wouters, B. G., Eliasof, S. D., & Kerbel, R. S. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.05.002 · Cited by 122
Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma
Guo, X., Li, D., Sun, K., Wang, J., Liu, Y., Song, J., Zhao, Q., Zhang, S., Deng, W.-J., Zhao, X., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0966-0 · Cited by 117
Tzeng, C.-W. D., & Aloia, T. A. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2022-3 · Cited by 111
Rahbari, N. N., Reißfelder, C., Schulze‐Bergkamen, H., Jäger, D., Büchler, M. W., Weitz, J., & Koch, M. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-174 · Cited by 68
Selvakumaran, M., Yao, K. S., Feldman, M. D., & O'Dwyer, P. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.029 · Cited by 60
Brenner, A. J., Floyd, J., Fichtel, L., Michalek, J. E., Kanakia, K. P., Huang, S., Reardon, D. A., Wen, P. Y., & Lee, E. Q. (2021) · Scientific Reports · doi:10.1038/s41598-021-81841-0 · Cited by 49
Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases
Maeda, Y., Shinohara, T., Nagatsu, A., Futakawa, N., & Hamada, T. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4460-0 · Cited by 48
Deacetylation of ATG4B promotes autophagy initiation under starvation
Sun, L., Xiong, H., Chen, L., Dai, X., Yan, X., Wu, Y., Yang, M., Shan, M., Li, T., Yao, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0412 · Cited by 43
Brenner, A. J., Zuniga, R. M., Sun, J. D., Floyd, J., Hart, C. P., Kroll, S., Fichtel, L., Cavazos, D., Caflisch, L., Gruslova, A., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy015 · Cited by 37
Gene Regulation in the Postgenomic Era: Technology Takes the Wheel
Dunn, R., & Kingston, R. E. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.022 · Cited by 19
Cited by
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 477
H3K18 Lactylation Potentiates Immune Escape of Non–Small Cell Lung Cancer
Zhang, C., Zhou, L., Zhang, M., Du, Y., Li, C., Ren, H., & Zheng, L. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3513 · Cited by 264
Emerging epigenetic modifications in renal fibrosis: From mechanisms to treatments
Suo, X., Ge, Q., Peng, L., Zhu, Q., Zhang, M., Cheng, X., Wang, F., Jin, J., Wang, J., & Meng, X. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.012 · Cited by 8
Metadata
- Authors
- Li, W., Zhou, C., Yu, L., Hou, Z., Liu, H., Kong, L., Xu, Y., He, J., Lan, J., Ou, Q., Fang, Y., Lu, Z., Wu, X., Pan, Z., Peng, J., & Lin, J.
- Venue
- Autophagy
- Publisher
- Informa UK Limited
- Published
- 2023-08-29
- Volume
- 20
- Issue
- 1
- Pages
- 114-130
- ISSN
- 1554-8627 (ISSN-L)
- 1554-8635
- OpenAlex
- W4386117144
- Cited by
- 461
- References
- 51
- FWCI
- 44.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.